Progress in intra-articular therapy.

Loading...
Thumbnail Image

Date

2014-01

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

370
views
893
downloads

Citation Stats

Abstract

Diarthrodial joints are well suited to intra-articular injection, and the local delivery of therapeutics in this fashion brings several potential advantages to the treatment of a wide range of arthropathies. Possible benefits over systemic delivery include increased bioavailability, reduced systemic exposure, fewer adverse events, and lower total drug costs. Nevertheless, intra-articular therapy is challenging because of the rapid egress of injected materials from the joint space; this elimination is true of both small molecules, which exit via synovial capillaries, and of macromolecules, which are cleared by the lymphatic system. In general, soluble materials have an intra-articular dwell time measured only in hours. Corticosteroids and hyaluronate preparations constitute the mainstay of FDA-approved intra-articular therapeutics. Recombinant proteins, autologous blood products and analgesics have also found clinical use via intra-articular delivery. Several alternative approaches, such as local delivery of cell and gene therapy, as well as the use of microparticles, liposomes, and modified drugs, are in various stages of preclinical development.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1038/nrrheum.2013.159

Publication Info

Evans, Christopher H, Virginia B Kraus and Lori A Setton (2014). Progress in intra-articular therapy. Nat Rev Rheumatol, 10(1). pp. 11–22. 10.1038/nrrheum.2013.159 Retrieved from https://hdl.handle.net/10161/8166.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.